Biotech Holding Structure

Jess Mah created a biotech venture holding company that partners with scientists to commercialize breakthrough scientific discoveries, particularly focused on bioelectricity research with scientist Mike Levin. The company provides infrastructure, funding connections, and commercialization expertise to turn lab research into viable biotech companies.

Key Points:

• Core Structure:

  • 12-person team at holding company
  • Partners with scientists to commercialize their research
  • Provides funding connections to wealthy investors
  • Handles business development and commercialization strategy

• Current Projects:

  • Selljaboo: Company working on overcoming drug resistance in cancer treatments
  • Anthrobots: Developing programmable human bio bots (featured in Nature)
  • Focus on bioelectricity research applications
    • Alternative to genetic modification approach
    • Can manipulate biological outcomes through bioelectric signals
    • Potential applications in cancer treatment and organ development

• Business Model:

  • Find promising scientific research lacking commercialization
  • Bring in experienced biotech executives to validate and develop strategy
  • Connect with wealthy investors for funding
  • Create separate companies for different applications
  • Focus on bold science with potential for major breakthroughs

• Competitive Advantage:

  • Access to unique scientific discoveries
  • Network of wealthy investors
  • Team of experts to evaluate and commercialize
  • Focus on unconventional approaches to major problems